Microdigital rises 8.7% amid upward trend in COVID-19 (diagnostics/treatments/vaccine development) theme

On the 19th, the COVID-19 (diagnosis/treatment/vaccine development, etc.) theme rose by 3.80% compared to the previous day, showing strength, while Microdigital, a related stock attracting attention, surged by 8.7% compared to the previous day.

[Graph] Major stock price changes in the COVID-19 (diagnosis/treatment/vaccine development, etc.) theme



According to the analysis by Thinkpool Robo Algorithm RASSI, Microdigital’s quant financial score was 5.81 points, ranking 46th in the quant financial ranking within the COVID-19 (diagnosis/treatment/vaccine development, etc.) related theme. This can be interpreted as Microdigital having relatively low investment attractiveness from a financial perspective. On the other hand, United Pharm ranked first in the quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top stocks by financial score within the theme


※ The quant financial score is the result of the Robo Algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.